ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q1 2023. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,660,972 | +26.1% | 64,400 | 0.0% | 6.98% | +48.6% |
Q2 2023 | $25,098,612 | +4.6% | 64,400 | 0.0% | 4.69% | +0.5% |
Q1 2023 | $23,994,152 | +5.0% | 64,400 | +6.8% | 4.67% | -11.4% |
Q4 2022 | $22,843,449 | +7.3% | 60,300 | 0.0% | 5.27% | +7.9% |
Q3 2022 | $21,289,000 | -6.8% | 60,300 | 0.0% | 4.89% | -8.3% |
Q2 2022 | $22,846,000 | +3.7% | 60,300 | -13.7% | 5.33% | -1.9% |
Q1 2022 | $22,040,000 | +1.0% | 69,900 | +12.1% | 5.43% | +2.1% |
Q4 2021 | $21,828,000 | +34.8% | 62,332 | +16.2% | 5.32% | +3.5% |
Q3 2021 | $16,197,000 | +1.1% | 53,632 | +0.8% | 5.14% | -6.6% |
Q2 2021 | $16,027,000 | +36.5% | 53,232 | +24.9% | 5.50% | +19.3% |
Q1 2021 | $11,740,000 | +103.8% | 42,632 | +117.7% | 4.61% | +25.1% |
Q4 2020 | $5,760,000 | – | 19,587 | – | 3.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |